BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15288357)

  • 1. Consideration of Rituximab for fibrodysplasia ossificans progressiva.
    Altschuler EL
    Med Hypotheses; 2004; 63(3):407-8. PubMed ID: 15288357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva.
    Kitterman JA; Kantanie S; Rocke DM; Kaplan FS
    Pediatrics; 2005 Nov; 116(5):e654-61. PubMed ID: 16230464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigen B27 allele is not correlated with fibrodysplasia ossificans progressiva.
    Calvert GT; Shore EM
    Clin Orthop Relat Res; 1998 Jan; (346):66-70. PubMed ID: 9577412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal treatment of fibrodysplasia ossificans progressiva with surgical excision of heterotopic bone, indomethacin, and irradiation.
    Benetos IS; Mavrogenis AF; Themistocleous GS; Kanellopoulos AD; Papagelopoulos PJ; Soucacos PN
    J Surg Orthop Adv; 2006; 15(2):99-104. PubMed ID: 16919202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrodysplasia ossificans progressiva: diagnosis and surgical management.
    Trigui M; Ayadi K; Zribi M; Triki Z; Keskes H
    Acta Orthop Belg; 2011 Apr; 77(2):139-44. PubMed ID: 21667723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell involvement in fibrodysplasia ossificans progressiva.
    Gannon FH; Glaser D; Caron R; Thompson LD; Shore EM; Kaplan FS
    Hum Pathol; 2001 Aug; 32(8):842-8. PubMed ID: 11521229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva].
    Katagiri T; Kamizono J; Nakashima Y; Kitoh H; Susami T; Haga N
    Clin Calcium; 2010 Oct; 20(10):1510-7. PubMed ID: 20890033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrodysplasia ossificans progressiva (FOP).
    Paim LB; Liphaus Bde L; Almeida da Silva CA
    Indian Pediatr; 2003 Aug; 40(8):786-8. PubMed ID: 12951384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute lymphocytic infiltration in an extremely early lesion of fibrodysplasia ossificans progressiva.
    Gannon FH; Valentine BA; Shore EM; Zasloff MA; Kaplan FS
    Clin Orthop Relat Res; 1998 Jan; (346):19-25. PubMed ID: 9577406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy in treatment of fibrodysplasia ossificans progressiva: a case report and review of the literature.
    Soldić Z; Murgić J; Radić J; Dabelić N; Jazvić M; Brozić JM; Kusić Z
    Coll Antropol; 2011 Jun; 35(2):611-4. PubMed ID: 21755739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new mutation of the noggin gene in a French Fibrodysplasia ossificans progressiva (FOP) family.
    Fontaine K; Sémonin O; Legarde JP; Lenoir G; Lucotte G
    Genet Couns; 2005; 16(2):149-54. PubMed ID: 16080294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of the gene for fibrodysplasia ossificans progressiva (FOP) to chromosome 17q21-22.
    Lucotte G; Bathelier C; Mercier G; Gérard N; Lenoir G; Sémonin O; Fontaine K;
    Genet Couns; 2000; 11(4):329-34. PubMed ID: 11140409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A description of two surgical and anesthetic management techniques used for a patient with fibrodysplasia ossificans progressiva.
    Wadenya R; Fulcher M; Grunwald T; Nussbaum B; Grunwald Z
    Spec Care Dentist; 2010; 30(3):106-9. PubMed ID: 20500705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wrist arthrodesis following ulnar bar excision in Fibrodysplasia ossificans progressiva.
    Corfield L; Hampton R; McCullough CJ
    J Hand Surg Br; 2000 Apr; 25(2):223-4. PubMed ID: 11062587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP).
    Hsiao EC; Di Rocco M; Cali A; Zasloff M; Al Mukaddam M; Pignolo RJ; Grunwald Z; Netelenbos C; Keen R; Baujat G; Brown MA; Cho TJ; De Cunto C; Delai P; Haga N; Morhart R; Scott C; Zhang K; Diecidue RJ; Friedman CS; Kaplan FS; Eekhoff EMW
    Br J Clin Pharmacol; 2019 Jun; 85(6):1199-1207. PubMed ID: 30281842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anesthesia in a child with fibrodysplasia ossificans progressiva.
    Vashisht R; Prosser D
    Paediatr Anaesth; 2006 Jun; 16(6):684-8. PubMed ID: 16719887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lumbar puncture and surgical intervention in a child with undiagnosed fibrodysplasia ossificans progressiva.
    Zaghloul KA; Heuer GG; Guttenberg MD; Shore EM; Kaplan FS; Storm PB
    J Neurosurg Pediatr; 2008 Jan; 1(1):91-4. PubMed ID: 18352811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intravenous etidronate and oral corticosteroids in fibrodysplasia ossificans progressiva.
    Brantus JF; Meunier PJ
    Clin Orthop Relat Res; 1998 Jan; (346):117-20. PubMed ID: 9577418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the noggin (NOG) and of the activin A type I receptor (ACVR1) genes in a series of twenty-seven French fibrodysplasia ossificans progressiva (FOP) patients.
    Lucotte G; Houzet A; Hubans C; Lagarde JP; Lenoir G
    Genet Couns; 2009; 20(1):53-62. PubMed ID: 19400542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational screening of ACVR1 gene in Brazilian fibrodysplasia ossificans progressiva patients.
    Carvalho DR; Navarro MM; Martins BJ; Coelho KE; Mello WD; Takata RI; Speck-Martins CE
    Clin Genet; 2010 Feb; 77(2):171-6. PubMed ID: 19796185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.